Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UTIW
701
DELISTED
UTI WORLDWIDE INC
UTIW
| $12.9M | 0.03% |
+1,244,551
| New | +$12.3M |
|
|
PPP
702
DELISTED
Primero Mining Corp
PPP
| $12.9M | 0.03% |
1,605,104
+404,400
| +34% | +$2.73M |
|
703
Canadian Imperial Bank of Commerce
CM
$112B
| $12.8M | 0.03% |
287,898
-226,201
| -44% | -$9.83M |
|
|
ASCMA
704
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $12.8M | 0.03% |
194,026
-4,674
| -2% | -$311K |
|
|
SIR
705
DELISTED
SELECT INCOME REIT
SIR
| $12.8M | 0.03% |
980,070
+947,992
| +2,955% | +$12.4M |
|
706
Smith & Nephew
SNN
$12.6B
| $12.8M | 0.03% |
357,500
+147,000
| +70% | +$4.81M |
|
|
HA
707
DELISTED
Hawaiian Holdings, Inc.
HA
| $12.8M | 0.03% |
930,700
+159,793
| +21% | +$2.31M |
|
|
MTOR
708
DELISTED
MERITOR, Inc.
MTOR
| $12.7M | 0.03% |
977,500
-225,700
| -19% | -$2.97M |
|
|
CBK
709
DELISTED
Christopher & Banks Corporation
CBK
| $12.7M | 0.03% |
1,444,400
+77,394
| +6% | +$535K |
|
710
Koppers
KOP
$874M
| $12.6M | 0.03% |
330,600
+18,508
| +6% | +$725K |
|
711
Western Alliance Bancorporation
WAL
$8.92B
| $12.6M | 0.03% |
531,200
-122,064
| -19% | -$2.87M |
|
|
MR
712
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
| $12.6M | 0.03% |
400,500
+188,350
| +89% | +$5.98M |
|
713
First American
FAF
$7.56B
| $12.6M | 0.03% |
453,300
-106,745
| -19% | -$2.91M |
|
|
ENLC
714
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $12.6M | 0.03% |
301,532
+271,200
| +894% | +$10.4M |
|
|
FNHC
715
DELISTED
FedNat Holding Company Common Stock
FNHC
| $12.5M | 0.03% |
490,100
+115,600
| +31% | +$2.53M |
|
716
Philips
PHG
$26.8B
| $12.5M | 0.03% |
567,155
+316,190
| +126% | +$7.11M |
|
|
AXON
717
Axon Enterprise
AXON
$50B
| $12.5M | 0.03% |
938,452
-1,504,900
| -62% | -$22.4M |
|
718
Icahn Enterprises
IEP
$5.33B
| $12.5M | 0.03% |
125,025
+96,401
| +337% | +$9.66M |
|
719
Corpay
CPAY
$27.9B
| $12.4M | 0.03% |
94,400
-264,900
| -74% | -$32.4M |
|
720
LCI Industries
LCII
$2.6B
| $12.4M | 0.03% |
248,506
+59,289
| +31% | +$2.96M |
|
|
AWH
721
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $12.3M | 0.03% |
323,800
-187,025
| -37% | -$6.81M |
|
722
Aon
AON
$75.7B
| $12.3M | 0.03% |
136,601
-28,345
| -17% | -$2.45M |
|
|
ANSS
723
DELISTED
Ansys
ANSS
| $12.3M | 0.03% |
161,929
-83,855
| -34% | -$6.29M |
|
724
AudioCodes
AUDC
$253M
| $12.3M | 0.03% |
1,739,000
+5,100
| +0.3% | +$33.2K |
|
|
ETP
725
DELISTED
Energy Transfer Partners, L.P.
ETP
| $12.3M | 0.03% |
+260,200
| New | +$11.8M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.